Skip to main content

Day: November 26, 2019

SEB publishes historical transactional data for the Baltics

SEB publishes historical transactional data for the BalticsSince 2006, SEB has taken considerable measures in order to minimize the risk of being exploited for money laundering in the Baltics. This is shown in the historical transactional data for Estonia 2005–2018, which SEB publishes today. The text below is related to the enclosed graph, which provides further details on the aforementioned transactional flows.   – We want to continue being transparent and have now presented our historical data for the Baltic region in more detail. We have been perceptive to signals of foul play and taken action, when needed. In the comprehensive analysis that we have made of our business in the Baltics, we have not seen that SEB has been used for money laundering in a systematic way. Still, at any given time, all banks are subjected to the risks that...

Continue reading

SEB publicerar historisk transaktionsdata gällande Baltikum

SEB publicerar historisk transaktionsdata gällande BaltikumSedan 2006 har SEB tagit betydande steg för att minska risken att utnyttjas för penningtvätt i Baltikum. Det visar de historiska transaktionsflöden för Estland 2005-2018 som banken idag publicerar. Texten nedan relaterar till bifogad graf med detaljer kring dessa flöden.– Vi vill fortsätta att vara transparenta och väljer nu att mer i detalj redovisa historisk data från den baltiska verksamheten. Vi har agerat, lyssnat på de signaler vi fått och vidtagit åtgärder. Med grund i den omfattande analys vi gjort av bankens historia i Baltikum har vi inte kunnat se att SEB systematiskt har utnyttjats för penningtvätt. Vi kan samtidigt konstatera att både SEB och andra banker ständigt lever med riskerna som finansiell brottslighet innebär, säger Johan Torgeby, vd och koncernchef.Från...

Continue reading

Aquestive Therapeutics Announces Poster Presentations of Data on Libervant™ (diazepam) Buccal Film at American Epilepsy Society 2019 Annual Meeting

Company to Host Scientific Exhibit on Monday, December 9 from 8:00 am ET to 11:00 am ETCompany to Host Investor & Analyst Libervant Update Forum and Webcast on Monday, December 9 at 4:00 pm ETWARREN, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients’ unmet needs and solve therapeutic problems, today announced that data from five abstracts, including two “late-breakers”, related to its therapeutic candidate, Libervant™ (diazepam) Buccal Film, will be presented at the American Epilepsy Society (AES) 2019 Annual Meeting, taking place December 6-10, 2019 in Baltimore.In addition to the poster presentations, Aquestive will host a Scientific Exhibit on Monday, December 9th from 8:00...

Continue reading

Ikänik Farms Completes Initial Heavy Metals Analysis of Sample Flower with Leading Colombian Laboratories

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESInitial lab results indicate Ikänik’s Colombian production processes support stringent European pharmaceutical regulationsVANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) — Canadian Imperial Venture Corp. (TSXV:CQV.H) (the “Company”) is pleased to announce that Ikänik International, Inc. (“Ikänik International”), a wholly owned subsidiary of Ikänik Farms, Inc. (“Ikänik Farms”), represented by its medical division in Colombia, Pideka SAS (“Pideka”), has successfully completed initial heavy metals analysis of flower samples grown at “Casa Flores”, the Company’s state-of-the-art 80,000 sq. ft. cannabis camp located in Tocancipá, Colombia, currently under construction.“We are pleased to present passing results from our initial...

Continue reading

Hagar hf. endurnýja samning við Kviku banka hf. um viðskiptavakt

Hagar hf. hafa í dag endurnýjað samning við Kviku banka hf. um viðskiptavakt á hlutabréfum útgefnum af Högum í Kauphöll Íslands NASDAQ OMX Iceland. Eldri samningur er frá ágúst 2019.Kvika banki hf. skuldbindur sig til að setja fram dag hvern kaup- og sölutilboð í hlutabréf félagsins í viðskiptakerfi kauphallar. Fjárhæð kaup- og sölutilboða skal vera 400.000 að nafnvirði, en þó aldrei hærri en 30 milljónir að markaðsvirði, á gengi sem Kvika ákveður í hvert skipti. Verði tilboðum Kviku tekið skal Kvika setja fram annað tilboð innan 15 mínútna frá síðustu viðskiptum. Hámarksverðbil kaup- og sölutilboða skal vera 2,5%. Ef verðbreyting á hlutabréfum Haga innan dags nær 10% er Kviku heimilt að tvöfalda hámarksverðbil kaup- og sölutilboða tímabundið það sem eftir er dagsins. Hámarksfjárhæð heildarviðskipta dag hvern sem Kvika er skuldbundin...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.